CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project addresses the urgent need for new technologies to combat antibiotic resistance in bacteria. It focuses on assessing the commercial viability of innovative approaches to tackle the public health threat posed by resistant infections.
Multidrug resistance of pathogenic bacteria has become a serious threat to public health.
The need to develop novel technologies to combat the evolution of bacterial drug resistance is clearly a matter of public concern and urgency.
The consequences of AMR include (i) reducing our ability to treat common infectious, resulting in prolonged illness and a greater risk of complications; (ii) patients remaining infectious for longer due to ineffective treatments, making them more likely to pass infec…
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
